Showing results (221-230 of 300) with videos related to

Sort By:
Pageof 30
Journal of the American College of Cardiology|June 19, 2007
Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcomeDavid Conen, Ludovic Melly, Christoph Kaufmann, et al.
Medicine and Science in Sports and Exercise|January 14, 2025
Reduced Lower Body Muscular Strength and Endurance among Adult Survivors of Childhood CancerTomáš Sláma, Carina Nigg, Reto D Kurmann, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)Isabella Sudano, Francois Mach, Tiziano Moccetti, et al.
International Journal of Cardiology|August 24, 2014
Long-term comparison of cryoballoon and radiofrequency ablation of paroxysmal atrial fibrillation: a propensity score matched analysisSven Knecht, Christian Sticherling, Stefanie von Felten, et al.
Pacing and Clinical Electrophysiology : PACE|October 19, 2019
The Medtronic Sprint Fidelis® lead history revisited-Extended follow-up of passive leadsSimon Martin Frey, Christian Sticherling, David Altmann, et al.
Indian Pacing and Electrophysiology Journal|November 8, 2017
RIght VErsus Left Apical transvenous pacing for bradycardia: Results of the RIVELA randomized studyHaran Burri, Hajo Müller, Richard Kobza, et al.
Circulation. Heart Failure|October 5, 2020
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart FailureDavid E Lanfear, Jasmine A Luzum, Ruicong She, et al.
American Heart Journal|February 28, 2016
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trialGiuseppe Vassalli, Catherine Klersy, Stefano De Servi, et al.
American Heart Journal|December 3, 2014
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durationsRaban V Jeger, Matthias E Pfisterer, Rikke Sørensen, et al.
JACC. Heart Failure|March 14, 2014
Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure)Sandra Sanders-van Wijk, Antoinette D I van Asselt, Hans Rickli, et al.
Pageof 30